Support Line: 0800 002 9002
General Enquiries: 01223 870008


News Archive

Featured

Pembrolizumab recommended as an adjuvant therapy for RCC across UK

Pembrolizumab recommended as an adjuvant therapy for RCC across UK

The Scottish Medical Consortium have recommended Pembrolizumab (Keytruda) as a monotherapy which is indicated for ...
Highlights from the ESMO Congress 2022

Highlights from the ESMO Congress 2022

We are delighted to share with you the report from The European Society of Medical Oncology (ESMO) congress 2022 ...
No results found.